| Nov 10, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 2,000 | $8.45 | $17K@ $8.45 | 2,194,579 | Form 4 |
| Nov 10, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 20,700 | $8.45 | $175K@ $8.45 | 5,255,278 | Form 4 |
| Nov 9, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 16,000 | $8.24 | $132K@ $8.24 | 2,192,579 | Form 4 |
| Nov 9, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 4,000 | $8.24 | $33K@ $8.24 | 5,234,578 | Form 4 |
| Nov 6, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 39,600 | $7.85 | $311K@ $7.85 | 2,176,579 | Form 4 |
| Nov 6, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 9,816 | $7.85 | $77K@ $7.85 | 5,230,578 | Form 4 |
| Nov 5, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 125,200 | $7.31 | $915K@ $7.31 | 2,136,979 | Form 4 |
| Nov 5, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 30,891 | $7.31 | $226K@ $7.31 | 5,220,762 | Form 4 |
| Nov 4, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 20,000 | $7.07 | $141K@ $7.07 | 2,011,779 | Form 4 |
| Nov 4, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 5,000 | $7.07 | $35K@ $7.07 | 5,189,871 | Form 4 |
| Nov 4, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 37,100 | $7.78 | $289K@ $7.78 | 1,991,779 | Form 4 |
| Nov 4, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 9,267 | $7.78 | $72K@ $7.78 | 5,184,871 | Form 4 |
| Nov 3, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 98,600 | $7.88 | $777K@ $7.88 | 1,954,679 | Form 4 |
| Nov 3, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 24,400 | $7.88 | $192K@ $7.88 | 5,175,604 | Form 4 |
| Nov 3, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 97,800 | $7.84 | $767K@ $7.84 | 1,856,079 | Form 4 |
| Nov 3, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 24,313 | $7.84 | $191K@ $7.84 | 5,151,204 | Form 4 |
| Sep 28, 2026 | ADRXDirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 588,235 | $17.00 | $10.0M@ $17.00 | 588,235 | Form 4 |
| Sep 28, 2026 | ADRXDirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC, Chimovits Erez | 61,516 | $17.00 | $1.0M@ $17.00 | 9,292,025 | Form 4 |
| Sep 28, 2026 | ADRXDirector | Conversion of derivativeCode C · indirect | 256,448 | — | — | 9,230,509 | Form 4 |
| Sep 28, 2026 | ADRXDirector | Conversion of derivativeCode C · indirect | 513,067 | — | — | 8,974,061 | Form 4 |
| Sep 28, 2026 | ADRXDirector | Conversion of derivativeCode C · indirect | 1,333,975 | — | — | 8,460,994 | Form 4 |
| Sep 28, 2026 | ADRXDirector | Conversion of derivativeCode C · indirect | 7,127,019 | — | — | 7,127,019 | Form 4 |
| Sep 28, 2026 | ADRXDirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 300,249 | $17.00 | $5.1M@ $17.00 | 14,325,529 | Form 4 |
| Sep 28, 2026 | ADRXDirector | Conversion of derivativeCode C · indirect | 564,187 | — | — | 14,025,280 | Form 4 |
| Sep 28, 2026 | ADRXDirector | Conversion of derivativeCode C · indirect | 769,601 | — | — | 13,461,093 | Form 4 |
| Sep 28, 2026 | ADRXDirector | Conversion of derivativeCode C · indirect | 2,000,962 | — | — | 12,691,492 | Form 4 |
| Sep 28, 2026 | ADRXDirector | Conversion of derivativeCode C · indirect | 10,690,530 | — | — | 10,690,530 | Form 4 |
| Sep 21, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 1,000,000 | $15.00 | $15.0M@ $15.00 | 1,758,279 | Form 4 |
| Sep 21, 2026 | ETRADirector | Conversion of derivativeCode C · indirect | 758,279 | — | — | 758,279 | Form 4 |
| Sep 21, 2026 | ETRADirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 333,333 | $15.00 | $5.0M@ $15.00 | 5,126,891 | Form 4 |
| Sep 21, 2026 | ETRADirector | Conversion of derivativeCode C · indirect | 1,703,314 | — | — | 4,793,558 | Form 4 |
| Sep 21, 2026 | ETRADirector | Conversion of derivativeCode C · indirect | 1,087,934 | — | — | 3,090,244 | Form 4 |
| Sep 21, 2026 | ETRADirector | Conversion of derivativeCode C · indirect | 2,002,310 | — | — | 2,002,310 | Form 4 |
| Aug 10, 2026 | BLSMDirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 625,000 | $16.00 | $10.0M@ $16.00 | 2,714,279 | Form 4 |
| Aug 10, 2026 | BLSMDirector | Conversion of derivativeCode C · indirect | 1,049,283 | — | — | 2,089,279 | Form 4 |
| Aug 10, 2026 | BLSMDirector | Conversion of derivativeCode C · indirect | 1,039,996 | — | — | 1,039,996 | Form 4 |
| Aug 6, 2026 | BLSM | Grant or awardCode A · direct | 23,904 | — | — | 23,904 | Form 4 |
| Jul 27, 2026 | SCTXDirector | Conversion of derivativeCode C · indirect | 2,065,672 | — | — | 0 | Form 4 |
| Jul 27, 2026 | SCTXDirector | Open-market purchaseCode P · indirectAlso reported by ORBIMED ADVISORS LLC | 1,000,000 | $15.00 | $15.0M@ $15.00 | 1,348,825 | Form 4 |
| Jul 27, 2026 | SCTXDirector | Conversion of derivativeCode C · indirect | 348,825 | — | — | 348,825 | Form 4 |
| Jul 23, 2026 | SCTX | Grant or awardCode A · direct | 14,725 | — | — | 14,725 | Form 4 |
| Jan 2, 2026 | CMPXDirector | Grant or awardCode A · direct | 90,000 | — | — | 90,000 | Form 4 |
| Nov 21, 2025 | KROSDirector | Disposition to issuerCode D · indirect | 74,465 | $17.75 | $1.3M@ $17.75 | 45,057 | Form 4 |
| Nov 21, 2025 | KROSDirector | Disposition to issuerCode D · indirect | 140,057 | $17.75 | $2.5M@ $17.75 | 759,155 | Form 4 |